Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ.

Ann Neurol. 2010 Sep;68(3):319-29. doi: 10.1002/ana.22068.

PMID:
20687209
2.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
3.

Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment.

Zhang S, Han D, Tan X, Feng J, Guo Y, Ding Y.

Int J Clin Pract. 2012 Feb;66(2):185-98. doi: 10.1111/j.1742-1241.2011.02845.x. Review.

PMID:
22257044
4.

[Amyloid PET in Alzheimer research].

Ishii K.

Brain Nerve. 2010 Jul;62(7):757-67. Review. Japanese.

PMID:
20675880
5.
6.

Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment.

Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, Knoll P, Zajicek B, Dudczak R, Mostbeck G, Kuntner C, Langer O, Bruecke T, Mirzaei S.

Curr Alzheimer Res. 2009 Jun;6(3):312-9. Review.

PMID:
19519314
7.

[Molecular PET imaging for in vivo detection of amyloid in the human brain].

Okamura N.

Rinsho Shinkeigaku. 2009 Nov;49(11):922-4. Review. Japanese.

PMID:
20030249
8.

[Molecular imaging of beta-amyloid plaques in the brain].

Ono M.

Brain Nerve. 2007 Mar;59(3):233-40. Review. Japanese.

PMID:
17370649
9.

Application of pet imaging to diagnosis of Alzheimer's disease and mild cognitive impairment.

Noble JM, Scarmeas N.

Int Rev Neurobiol. 2009;84:133-49. doi: 10.1016/S0074-7742(09)00407-3. Review.

10.

Clinical amyloid imaging in Alzheimer's disease.

Herholz K, Ebmeier K.

Lancet Neurol. 2011 Jul;10(7):667-70. doi: 10.1016/S1474-4422(11)70123-5. Review.

PMID:
21683932
11.

2-{3-[18F]Fluoro-4-(methylamino)phenyl}-1,3-benzothiazol-6-ol.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Nov 14 [updated 2012 Dec 27].

12.

Positron emission tomography scans obtained for the evaluation of cognitive dysfunction.

Silverman DH, Mosconi L, Ercoli L, Chen W, Small GW.

Semin Nucl Med. 2008 Jul;38(4):251-61. doi: 10.1053/j.semnuclmed.2008.02.006. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk